Breathe New Life Into Your Nasal Obstruction Cases.

Vivaer® Nasal Airway Remodeling
Patients suffering from nasal airway obstruction want a minimially invasive, lasting solution. With Vivaer® Nasal Airway Remodeling, you can offer many patients the ability to breathe better and live better. Vivaer® treatment utilizes proprietary low-temperature, RF energy to effectively reshape the nasal airway to improve airflow, without any incisions.

No Incisions

Low-temperature RF with proprietary treatment algorithms delivers controlled energy to target areas and reduces tissue, reshaping the nasal airway.

In-Office Procedure

Vivaer® treatment integrates easily in your practice with minimal disruption of workflow.

Clinically Proven Results

Clinical studies have shown significant improvements in nasal airflow, NOSE scores (Nasal Obstruction Symptom Evaluation), and quality of life, similar to surgical outcomes.

Go Beyond Traditional Treatment Options.

Help More of Your Patients Breathe Easy.
The Vivaer® procedure fills a significant treatment gap for a very large group of patients already in your practice and allows you to help them finally breathe freely.

  • An estimated 4 million patients already under the care of otolaryngologists could benefit from this procedure
  • Every year, approximately 600,000 new cases are diagnosed in the US alone

Patients are highly interested in the procedure.
In recent surveys conducted with patients suffering from severe or extreme nasal obstruction symptoms:

Of potential patients presented with a description of Vivaer® said they were interested in undergoing the procedure

Of potential patients were ready to pay out of pocket for the procedure

Proprietary Energy. Remodeled Airways.

RF Remodeling with Proprietary Treatment Algorithms
The Vivaer® Nasal Airway Remodeling platform delivers radiofrequency energy using proprietary control algorithms to reduce tissue in the nasal airway. The smart console instantly sets treatment parameters when the Vivaer® Stylus is inserted. The stylus is then used to gently reduce submucosal tissues, that obstruct the nasal airway.

Vivaer® Treatment Platform

Small Changes Make Large Improvements to Nasal Breathing
The nasal valve area, the most common site of nasal obstruction, accounts for over two thirds of total nasal resistance. Changes to the valve area result in large improvements to airflow and nasal breathing.

  • No Incisions – The procedure requires no incisions and is performed by treating at the surface of the desired area
  • No exterior change – Gently heats and reduces submucosal tissue, including cartilage, to relieve nasal obstruction without impacting exterior appearance of the nose




The Evidence is Clear. And So are the Results.

Clinical Studies Demonstrate Surgery-like Results1
A prospective, multi-center, non-randomized US Pivotal Study to evaluate the treatment of nasal airway obstruction using the Vivaer® Treatment Platform demonstrated outstanding patient outcomes (data on file).

NOSE Score
Mean with 95% C.I.

Decrease in the mean NOSE score at 24 months

Patients evaluated were classified as responders at 24 months

Patients reported an improved sleep quality

Patients reported improved ability to get enough air through their nose during exercise or exertion

Inside Your Office. Beyond Expectations.

Now, you can address a patient population – many of whom are already in your own practice – with an option that is in-office, offers immediate recovery, and shows significant improvements in nasal breathing.

In-office Treatment:
• Treatment designed and optimized for the office environment
• Requires only local anesthetic, with minimal patient discomfort
• Direct visualization of treatment locations – no endoscope necessary
• Patients can immediately return to normal activities

Fast, Straightforward Procedure

Treatment time of 30 seconds per site, typically three sites per nostril.

Total procedure time under 30 minutes, including local anesthesia dwell time.

  1. Rhee, JS et al. A Systematic Review of Patient Reported Nasal Obstruction Scores, JAMA FacialPlastSurg. 2014;16(3):219-2